What is Fampyra?
Fampyra is the European name for ampyra; they are the same drug.
Please refer to my prior comments on Ampyra by using the search button on the web site
Briefly, Ampyra is a potassium channel blocker approved by the FDA to increase walking time in people with MS. The improvement in walking time has been associated with improvements self reported walking quality and performance.
Revere (Rip) Kinkel MD
Director of the Multiple Sclerosis Program
Professor of Clinical Neurosciences
University of California San Diego
PLEASE NOTE: The information/opinions on this site should be used as an information resource only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.